Recent International Antitrust Developments in Health Care and Pharmaceuticals - November 2015 through May 2016
10 AM EDT
Second installment of the International Antitrust Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals markets outside of the U.S. It has become paramount to approach antitrust issues from a global perspective in these markets; companies deal with many of the same core antitrust issues inside and outside of the U.S. but are often subject to varying standards and levels of enforcement. This new initiative aims to provide in-house and external antitrust practitioners with a solid understanding of key differences across jurisdictions, as well as an overview of major developments.
* Lauren Battaglia, Hogan Lovells, Washington D.C.
* Jan Blockx, Hogan Lovells, Brussels
* Sabrina Borocci, Hogan Lovells, Milan
* Tim Capel, Hogan Lovells, London
* Zhang Jiaming, Hogan Lovells, Beijing
* Luis Omar Guerrero R., Hogan Lovells, Mexico
* Eric Paroche, Hogan Lovells, Paris
FREE: Antitrust Section Members, Government, Non-profit Employees, Students
$25 Other Non-Members
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.